Keywords: Blood pathogen inactivation, Transfusion-transmitted diseases, Hepatitis, Frost & Sullivan

European blood pathogen inactivation market set to more than double by 2013

Article | 13 October 2010

Although remarkable advances have been made in the prevention of the major transfusion-transmitted diseases, long intervals have transpired between the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in